Your session is about to expire
← Back to Search
Exercise for Ovarian and Endometrial Cancer Patients
Study Summary
This trial is testing whether a 16-week program of aerobic and resistance exercises, done at home with virtual supervision, is feasible for ovarian and endometrial cancer patients who are receiving first-line chemotherapy, and if it will improve leg function or reduce chemotherapy-induced numbness/tingling in the extremities.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have any uncontrolled illnesses as determined by my oncologist.I have had chemotherapy for cancer before.I have stage III-IV ovarian or endometrial cancer and am starting chemotherapy with carboplatin and paclitaxel after surgery.You have existing muscle, nerve, heart, or lung problems, as decided by your doctor.I am 18 years old or older.
- Group 1: Exercise
- Group 2: Attention Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How extensive is the enrollment for this clinical trial?
"Indeed, as evidenced by clinicaltrials.gov, this medical experiment is actively looking for participants. It was initially posted on April 2nd 2022 and last revised on May 4th 2022 with the aim of recruiting 30 people from 1 trial site."
Are more participants being sought for this clinical experiment?
"According to the clinicaltrials.gov website, this medical experiment is actively enrolling patients into its study as of now. The trial was published on April 2nd 2022 and has been recently updated on May 4th 2022."
What is the purpose behind this clinical experiment?
"This 16 week clinical trial will measure the proportion of participants who successfully complete their prescribed exercise regimen. Secondary objectives include tracking any Adverse Events (as defined by NCI's CTCAE version 5), assessing Physical Function through PROMIS-10, and analyzing changes in Aerobic Fitness via the 6 Minute Walk Test - a reliable measurement with an R2 coefficient of 0.93."
Share this study with friends
Copy Link
Messenger